Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585858 · ClinicalTrials.gov registry record
Cytokine Kinetics Test to Assess the Presence or Absence of Tolerance in Organ Transplant
A clinical trial, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- 15
- Enrollment target
NCT00585858: Clinical Trial study, sponsored by University of Wisconsin, Madison.
NCT00585858 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00585858 was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to determine if there is clinical correlation between the CKT and transplant recipients who are known to be on minimal or no immunosuppression (presumed tolerant) and those who are on conventional amounts of immunosuppression and have either experienced rejection (presumed hyper-responsive to donor) or have not experienced rejection (unknown responsive state).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2006-09 |
| Est. Completion | 2008-06 |
Why NCT00585858 stopped before completion
NCT00585858 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00585858 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00585858 about?
NCT00585858 is a clinical study titled "Cytokine Kinetics Test to Assess the Presence or Absence of Tolerance in Organ Transplant". The purpose of this pilot study is to determine if there is clinical correlation between the CKT and transplant recipients who are known to be on minimal or no immunosuppression (presumed tolerant) and those who are on conventional amounts of immunosuppression and have either experienced rejection (...
What is the current status of trial NCT00585858?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2006-09. Estimated completion is 2008-06.
Who is sponsoring clinical trial NCT00585858?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia